Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
March 18, 2024 08:30 ET
|
Journey Medical Corporation
SCOTTSDALE, Ariz., March 18, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily...
Acute Bacterial Skin and Skin Structure Infections Market Projections Reveal Dynamic Growth in Asia Pacific Region Amid Global Rise to USD 2.31 Billion by 2034
March 18, 2024 05:11 ET
|
Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Global Acute Bacterial Skin and Skin Structure Infections Market by Type of Infection, Route of Administration, Distribution Channel, and By Region"...
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
March 15, 2024 08:30 ET
|
Journey Medical Corporation
SCOTTSDALE, Ariz., March 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that focuses on the...
Common Skin Cancer, Like Christie Brinkley’s, Can Often Be Cured Without Surgery
March 14, 2024 17:42 ET
|
SkinCure Oncology LLC
Christie Brinkley was diagnosed with common skin cancer and her doctor “stitched me up to perfection,” but most such cancers can be cured without surgery.
Journey Medical Corporation to Participate in the 36th Annual ROTH Conference
March 13, 2024 08:30 ET
|
Journey Medical Corporation
SCOTTSDALE, Ariz., March 13, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling...
STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
March 13, 2024 08:00 ET
|
STRATA Skin Sciences, Inc.
HORSHAM, Pa., March 13, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and...
Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments
March 13, 2024 07:00 ET
|
Sol-Gel Technologies Ltd.
Sol-Gel Reports Full Year 2023 Financial Results and Corporate Developments
Dermatology Imaging Devices Market Report 2024, with Profiles of FotoFinder, e-con, Longport, Cortex Technology, VisualSonics, Clarius, Koninklijke Philips, Caliber Imaging and Diagnosis & DermLite
March 12, 2024 13:44 ET
|
Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Dermatology Imaging Devices Market Size, Share & Trends Analysis Report By Modality (Digital Photographic Imaging, OCT, Dermatoscope, High...
Global Photodynamic Therapy Devices Market Report 2024: Analysis of Products, Applications, End-users and Regional Dynamics to 2034 Featuring Coherent Corp, Biolitec, & Lumibird Medical Among Other Key Players
March 11, 2024 14:11 ET
|
Research and Markets
Dublin, March 11, 2024 (GLOBE NEWSWIRE) -- The "Global Photodynamic Therapy Devices Market Analysis & Forecast to 2024-2034: Market By Product; By Application; By End-user; and By Region" report...
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting
March 11, 2024 08:30 ET
|
Journey Medical Corporation
Clinical trial achieved all three primary objectives and subjects completed 16-week treatment with no significant safety issues Results indicate that DFD-29 can be safely used for up to 16 weeks with...